|
PKD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.20756746216466E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11359810262002E-11 |
| Normal-vs-Stage2 |
2.49919995809478E-09 |
| Normal-vs-Stage3 |
1.738609256563E-13 |
| Normal-vs-Stage4 |
6.62125909656197E-12 |
| Stage1-vs-Stage2 |
6.755200E-01 |
| Stage1-vs-Stage3 |
5.678100E-02 |
| Stage1-vs-Stage4 |
1.873610E-01 |
| Stage2-vs-Stage3 |
8.871800E-02 |
| Stage2-vs-Stage4 |
1.671990E-01 |
| Stage3-vs-Stage4 |
9.129000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.7470027081099E-12 |
| Normal-vs-AfricanAmerican |
2.35539999948742E-07 |
| Normal-vs-Asian |
6.66980004560003E-09 |
| Caucasian-vs-AfricanAmerican |
7.777200E-01 |
| Caucasian-vs-Asian |
3.248200E-01 |
| AfricanAmerican-vs-Asian |
3.778800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.99114075122498E-12 |
| Normal-vs-Female |
4.13813427968535E-12 |
| Male-vs-Female |
8.594200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.46529480058189E-11 |
| Normal-vs-Age(41-60Yrs) |
1.63835611743934E-12 |
| Normal-vs-Age(61-80Yrs) |
2.29549712571497E-12 |
| Normal-vs-Age(81-100Yrs) |
4.829000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.867770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.032400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.625200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.622800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.966600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.298000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.39830000023267E-07 |
| Classical-VS-Follicular |
1.269220E-01 |
| Classical-VS-Other |
7.483600E-01 |
| Classical-VS-Normal |
1.26230026431529E-10 |
| Tall-VS-Follicular |
1.075040E-03 |
| Tall-VS-Other |
2.321800E-01 |
| Tall-VS-Normal |
1.62481139653892E-12 |
| Follicular-VS-Other |
8.621400E-01 |
| Follicular-VS-Normal |
1.27140520334024E-11 |
| Other-VS-Normal |
3.077000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.85607126627019E-12 |
| Normal-vs-N1 |
5.96139804187601E-11 |
| N0-vs-N1 |
7.978000E-01 |
|
|
